All CYTK Content

Cytokinetics, Incorporated (CYTK) Sec Form 10K

Cytokinetics, Incorporated (NASDAQ: CYTK) Sec Form 10K

February 28, 20261 min read

Cytokinetics, Incorporated (CYTK) Sec Form 8K

Cytokinetics, Incorporated (NASDAQ: CYTK) Sec Form 8K

February 26, 20261 min read

Cytokinetics, Incorporated (CYTK) Q4 2025 Earnings Call

Cytokinetics, Incorporated (NASDAQ: CYTK) Q4 2025 Earnings Release

February 24, 20261 min read

Cytokinetics, Incorporated (CYTK) Sec Form 8K

Cytokinetics, Incorporated (NASDAQ: CYTK) Sec Form 8K

February 19, 20261 min read

Cytokinetics, Incorporated (CYTK) Cytokinetics Announces European Commission Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Cytokinetics, Incorporated (NASDAQ: CYTK) FY 2026 Other Release

February 17, 20261 min read

Cytokinetics, Incorporated (CYTK) Q4 2025 Earnings Call

Cytokinetics, Incorporated (NASDAQ: CYTK) Q4 2025 Earnings Conference

February 13, 20261 min read

Cytokinetics, Incorporated (CYTK) Q4 2025 Earnings Announcement

Cytokinetics, Incorporated (NASDAQ: CYTK) Q4 2025 Earnings Announcement

February 13, 20261 min read

Cytokinetics, Incorporated (CYTK) Cytokinetics Announces Recipients of Its Eighth Annual Communications Grant Program

Cytokinetics, Incorporated (NASDAQ: CYTK) FY 2026 Other Release

February 9, 20261 min read

Cytokinetics, Incorporated (CYTK) Q2 2025 Earnings Call Transcript

Cytokinetics, Incorporated (NASDAQ: CYTK) Q2 2025 Earnings Call dated Aug. 07, 2025 Corporate Participants: Diane Weiser — Senior Vice President, Corporate Aairs Robert I. Blum…

January 22, 202657 min read

Cytokinetics, Incorporated (CYTK) Q3 2025 Earnings Call Transcript

Cytokinetics, Incorporated (NASDAQ: CYTK) Q3 2025 Earnings Call dated Nov. 05, 2025 Corporate Participants: Diane Weiser — Senior Vice President of Corporate Affairs Robert I.…

January 22, 202643 min read